Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AX04	SOTIRA	G	Lenalidomide - 25mg	25mg	Capsule	76,719,234 L.L
L04AD01	SANDIMMUN	B	Ciclosporin - 50mg/ml	250mg/5ml	Injectable concentrated solution	6,992,013 L.L
L04AD01	SANDIMMUN NEORAL SOFT GELATIN	B	Ciclosporin - 50mg	50mg	Capsule, soft gelatin	4,309,703 L.L
L04AD01	SANDIMMUN NEORAL SOFT GELATIN	B	Ciclosporin - 25mg	25mg	Capsule, soft gelatin	2,385,320 L.L
L04AD01	SANDIMMUN NEORAL SOFT GELATIN	B	Ciclosporin - 100mg	100mg	Capsule, soft gelatin	8,264,592 L.L
L04AD01	SANDIMMUN NEORAL	B	Ciclosporin - 100mg/ml	100mg/ml	Solution	8,264,592 L.L
L04AC18	SKYRIZI	BioTech	Risankizumab - 75mg	75mg	Injectable solution	194,911,251 L.L
L04AC18	SKYRIZI	BioTech	Risankizumab - 150mg	150mg	Injectable solution	194,911,251 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	157,788,141 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	157,788,141 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	157,788,141 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 90mg	90mg	Injectable solution	157,788,141 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	235,593,517 L.L
L04AC05	STELARA	BioTech	Ustekinumab - 130mg	130mg	Injectable concentrate for solution	L.L
L04AC05	STELARA	BioTech	Ustekinumab - 45mg	45mg	Injectable solution	L.L
L04AC02	SIMULECT	BioTech	Basiliximab - 20mg	20mg	Injectable powder + solvent	137,661,787 L.L
L04AB06	SIMPONI	BioTech	Golimumab - 50mg/0.5ml	50mg/0.5ml	Injectable solution	75,598,955 L.L
L04AB06	SIMPONI	BioTech	Golimumab - 100mg/1ml	100mg/1ml	Injectable solution	75,598,955 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	18,264,981 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	17,079,643 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
L04AA10	SIROMUNE	G	Sirolimus - 1mg	1mg	Tablet, film coated	18,729,193 L.L
L03AX03	SII-ONCO-BCG	G	Bacillus Calmette- Guerin Strain - 40mg/ml (1-8x10⁸CFU)	40mg/ml	Injectable dry powder	6,987,981 L.L
L01XX02	SPECTRILA	BioTech	Asparaginase, recombinant - 10,000IU	10,000IU	Injectable powder for concentrate for solution	21,370,813 L.L
L01FG01	STIVANT	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrate for solution	27,359,527 L.L
L01FG01	STIVANT	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	14,719,570 L.L
L01EX05	STIVARGA	B	Regorafenib - 40mg	40mg	Tablet, film coated	L.L
L01EX05	STIVARGA	B	Regorafenib - 40mg	40mg	Tablet, film coated	272,778,486 L.L

...